2026 is set to be a big year for several ASX Healthcare Companies, especially companies in the pre-commercialisation stage. The two keys to get drugs or devices to market are…
We often hear about Gen Z trends Reshaping Society. And this is not just speculation -there’s growing evidence Gen Z (short for Generation Z and compromising of people born roughly…
Blinklab (ASX:BB1) is the answer to the question of how you could help children with autism - a response that begins with 'there's an app for that'.
There is precedent for…
Here are 5 ASX biotechs expecting clinical trial results in the next few months!
Dimerix (ASX:DXB)
Dimerix is in the middle of a Phase III trial or its DMX-200 drug…